Navigation Links
Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
Date:1/25/2008

s and uncertainties which may cause the Company's actual results in future periods to differ materially from forecasted results. A number of factors, including the Company's ability to successfully complete the clinical trials required for it to file a new drug application for CPP-109, its ability to complete such trials on a timely basis within the budgets established for such trials, whether the Company's trials, which are being conducted in the U.S. under FDA good clinical practice guidelines, will evidence that CPP-109 is safe and effective for the treatment of cocaine addiction and methamphetamine addiction, the Company's ability to protect its intellectual property and those other factors described in the Company's Annual Report on Form 10-K for 2006 and the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2007 that the Company has previously filed with the U.S. Securities and Exchange Commission ("SEC"), could adversely affect the Company. Copies of the Company's filings with the SEC are available from the SEC or may be obtained upon request from the Company. The Company does not undertake any obligation to update the information contained herein, which speaks only as of this date.


'/>"/>
SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
2. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
3. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
4. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
5. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
6. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
7. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
8. Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
9. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
10. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
11. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015  Merrimack Pharmaceuticals, Inc. (Nasdaq: ... liposome injection), also known as ,nal-IRI, in a Phase ... Francisco for high-grade glioma. Data were presented at the ... in Chicago, IL. Results from ... in patients with high-grade glioma when given intravenously.  ...
(Date:6/1/2015)... , June 1, 2015 ... body weight over large area and improve the quality ... pressure ulcer. These devices play a significant role in ... help reduce the need to turn or rotate an ... devices include mattress, mattresses overlay, and specialty beds. These ...
(Date:6/1/2015)... -- The Middle Eastern MRI systems market is fast growing. ... because of its higher sensitivity and use of non-ionizing radiations. ... available systems of MRI, open and closed. Open MRI systems ... do not enclose the patient in a tunnel. This prevents ... that one in every 6 patients suffers from claustrophobia hence ...
Breaking Medicine Technology:Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 5Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3Middle East Open System MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2
... DES MOINES, Iowa, Oct. 16 Protocol ... and announced a partnership,with Hallmark Insights to ... to users of the ConXus health improvement ... and fulfillment services,for reward points earned by ...
... K. Khouri, M.D. a noted Plastic,and Reconstructive Surgeon, ... a,clinical trial performing a minimally invasive breast reconstruction,technique ... grafts primarily on women who have had a ... Typically, breast reconstruction procedures involve major, "open",surgery that ...
Cached Medicine Technology:PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs 2New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study 2
(Date:6/1/2015)... (PRWEB) June 01, 2015 Unlike most generator ... three times for in-use periods compared to when the generator ... rate whether the client uses the generator or not. WPP ... and delivery in as little as a few hours — ... to store a portable generator onsite. , “Even minor business ...
(Date:6/1/2015)... Denver, CO (PRWEB) June 01, 2015 ... Creek Urgent Care center hosted the Cherry Creek ... new primary care clinic. Urgent care centers typically do ... clinic will allow AFC/Doctors Express Cherry Creek Urgent Care ... and annual physicals. , From 5:30 to 7:30 p.m. ...
(Date:6/1/2015)... June 01, 2015 Sharenote, a leading ... for the Healthcare Industry this week in Louisiana. The ... in four days to provide potential providers with the ... profitability, and monitor risk within their network. , ... and is being used by more than 250 practices. ...
(Date:6/1/2015)... There’s never a good time to be sick and ... illnesses. , As of June 1, OSF HealthCare is offering ... via the Internet. Patients throughout Illinois can access care whenever ... is busy. We know that getting in to see a ... make it easier,” said Jeffry Tillery, MD, Chief Transformation Officer ...
(Date:6/1/2015)... June 01, 2015 Hexagon Geospatial is ... is a new cloud-based subscription service that provides on-demand ... software. , Both ERDAS IMAGINE and ... Producer Online, which offers a subscription model for delivering ... need to be able to quickly and easily access ...
Breaking Medicine News(10 mins):Health News:Worldwide Power Products Offers “Budget Billing” Contingency Generator Rental Program; Guarantees Power for Peak of Hurricane Season and Beyond 2Health News:Grand Opening For AFC/Doctors Express Cherry Creek Primary Care Clinic 2Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3
... can help avoid fractures if they participate in sport ... people and can have devastating consequences, particularly if a hip ... take exercise to reduce the thinning of their bones. ... osteoporosis. Women are at particular risk of osteoporotic fractures as ...
... southern Thailand and then ambushed and killed four officials ... ,Insurgents burned down the school in Maikaen ... that more than 100 public schools reopened their ... to the brutal slaying of four teachers in neighbouring ...
... Barkin who recently starred in 'Ocean's 13' did not ... smelling of marijuana because she used to smoke ... chose to ignore the incident even though she knew ... ,She says: 'I used to smoke with ...
... Research from The University of Arizona Sarver Heart Center ... heart disease. Excessive body weight is associated ... left ventricle, the hearts pumping chamber. Known to physicians ... lead to heart failure and rhythm problems. ...
... family with atleast one parent smoking have five times as ... whose parents are non-smokers , according to a report published ... ,The study was led by researchers from the University of ... least one parent who smoked and 33 with nonsmoking parents) ...
... careful when handling antiques, for some could carry in them ... warns. Mirrors can be backed with mercury and tin ; ... and barometers, thermometers and lamps may have mercury in their ... can leak, particularly as seals age or when the items ...
Cached Medicine News:Health News:Exercise Reduces Fracture in Men 2Health News:Thai Separatists Burn School, Kill Four 2Health News:Smokers Blow Their Infants Health into Thin Air 2Health News:Mercury in Antiques can Pose a Hazard - Study 2
... BioZip Suture Anchor is a unique double loaded ... is made from Poly-L Lactic Acid (PLLA) and ... are attached to the suture ends for open ... repairs. The trocar tip inserter allows insertion with ...
... LactoSorb copolymer is an absorbable ... L-Lactic acid and 18% glycolic acid. ... such as 100% poly-L-lactic acid (PLLA) ... copolymer is substantially amorphous (without crystallinity), ...
... is an absorbable co-polymer synthesized from ... 18% glycolic acid. Unlike the homopolymers ... poly-L-lactic acid (PLLA) or 100% poly-glycolic ... amorphous (without crystallinity), meaning that its ...
... The USS Sports Medicine™ POLYSORB™ Soft Tissue Anchor ... to attach soft tissue to bone using sutures. ... prepared hole in the bone, and is used ... are made of a resorbable copolymer, derived from ...
Medicine Products: